As of Aug 28
| -0.15 / -0.61%|
The 5 analysts offering 12-month price forecasts for Mindray Medical International Ltd have a median target of 30.00, with a high estimate of 34.50 and a low estimate of 22.40. The median estimate represents a +21.90% increase from the last price of 24.61.
The current consensus among 7 polled investment analysts is to Hold stock in Mindray Medical International Ltd. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.